This session will present facility strategies for accelerating speed to market, integrating emerging technologies, better equipping the biopharmaceutical and biomanufacturing workforce, and delivering space to attract industry partners. Flad's Mike Moreland and Jim Gazvoda will examine current regulatory compliance and scalability drivers that propel facility design decisions, and they identify best practices for developing "GMP-like" environments, advancing new bio therapies for commercial and clinical translation, attracting and retaining talent, leveraging partner capabilities, and linking research to manufacturing readiness. As a session highlight, they will profile the facility infrastructure being put in place at Georgia Tech to establish a leadership position in healthcare innovation, precision medicine, biomanufacturing, and value-based healthcare delivery.